Press release
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2025
A Deadline is coming up on October 27, 2025 in the lawsuit for certain investors in LifeMD, Inc. (NASDAQ: LFMD).
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: October 27, 2025. LifeMD, Inc. (NASDAQ: LFMD) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges on behalf of purchasers of LifeMD, Inc. (NASDAQ: LFMD) common shares between May 7, 2025 and August 5, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 7, 2025 and August 5, 2025, the defendants made materially false and/or misleading statements and/or failed to disclose that the Defendants materially overstated LifeMD's competitive position, that the Defendants were reckless in raising LifeMD's 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound, and that as a result, defendants' statements about LifeMD's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.
Those who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2025 here
News-ID: 4226300 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of p …
An investigation on behalf of current long-term investors in shares of CTO Realty Growth, Inc. (NYSE: CTO) concerning potential breaches of fiduciary duties by certain directors and officers of CTO Realty Growth, Inc. was announced.
Investors who are current long term investors in CTO Realty Growth, Inc. (NYSE: CTO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a…
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDA …
An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options…
Lawsuit filed for Investors who purchased shares of Cepton, Inc. (formerly NASDA …
An investor, who purchased shares of Cepton, Inc. (formerly NASDAQ: CPTN), filed a lawsuit over alleged violations of Federal Securities Laws by Cepton, Inc. in connection with certain allegedly false and misleading statements made between July 29, 2024 and January 6, 2025.
Investors who purchased a significant amount of shares of Cepton, Inc. (formerly NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, have certain options and for certain…
More Releases for LifeMD
Telepsychiatry Market Size to Reach US$ 102.62 billion by 2033 - Exclusive Repor …
The global telepsychiatry market was valued at US$ 24.36 billion in 2024 and is projected to reach US$ 102.62 billion by 2033, growing at a CAGR of 16.6% during the forecast period 2025-2033.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/telepsychiatry-market?sg
Mergers & Acquisitions in Telepsychiatry (2025):
✅ Teladoc Health Acquires UpLift: In April 2025, Teladoc Health, a leader in virtual care, acquired UpLift, a tech-enabled provider of mental…
Lawsuit filed for Investors who lost money with shares of LifeMD, Inc. (NASDAQ: …
An investor, who purchased shares of LifeMD, Inc. (NASDAQ: LFMD), filed a lawsuit over alleged violations of Federal Securities Laws by LifeMD, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and for certain investors are short and strict deadlines running. Deadline: October 27, 2025. NASDAQ: LFMD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Allergy Diagnostics Market on Track for Strong Growth, Estimated to Grow at 13.5 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Allergy Diagnostics Market Through 2025?
Over the past few years, the size of the allergy diagnostics market has witnessed rapid expansion. It is expected to increase from $6.32 billion in 2024 to $7.05 billion in 2025, representing a compound annual growth rate (CAGR) of 11.6%. Factors such…
Allergy Diagnostics Global Market to Observe Highest Growth of $10.4 Billion wit …
"The new report published by The Business Research Company, titled ""Allergy Diagnostics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the allergy diagnostics market size has grown rapidly in recent years. It will grow from $5.77 billion in…
Allergy Diagnostics Market Size, Trends, Outlook By 2024-2033 |
The allergy diagnostics market size has grown rapidly in recent years. It will grow from $5.77 billion in 2023 to $6.48 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to rise in prevalence of allergies, investments in research and development of allergy diagnostics, changing dietary habits and environmental factors, government initiatives, rise in demand for…
Investigation announced for Long-Term Investors in shares of LifeMD, Inc. (NASDA …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of LifeMD, Inc.
Investors who are current long term investors in LifeMD, Inc. (NASDAQ: LFMD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in NASDAQ: LFMD stocks follows a lawsuit filed against LifeMD, Inc. over alleged securities laws…
